Lucira Health Balance Sheet Health
Financial Health criteria checks 3/6
Lucira Health has a total shareholder equity of $60.9M and total debt of $29.4M, which brings its debt-to-equity ratio to 48.3%. Its total assets and total liabilities are $189.2M and $128.3M respectively.
Key information
48.3%
Debt to equity ratio
US$29.41m
Debt
Interest coverage ratio | n/a |
Cash | US$39.77m |
Equity | US$60.89m |
Total liabilities | US$128.30m |
Total assets | US$189.19m |
Recent financial health updates
Recent updates
Lucira Health reports early data for point of care chlamydia and gonorrhea assays
Sep 29Lucira COVID & Flu test gets emergency use authorization from Health Canada
Aug 11Lucira Health Sees Strong Revenue Growth But Needs More Cash
Mar 10Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher
Nov 25Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?
Jun 29Lucira Health appoints medtech veteran Kevin Collins as CRO
May 28Health Canada issues 'authorization with conditions' for Lucira's COVID-19 test kit
Apr 26Financial Position Analysis
Short Term Liabilities: LHDX.Q's short term assets ($120.5M) exceed its short term liabilities ($82.5M).
Long Term Liabilities: LHDX.Q's short term assets ($120.5M) exceed its long term liabilities ($45.8M).
Debt to Equity History and Analysis
Debt Level: LHDX.Q has more cash than its total debt.
Reducing Debt: Insufficient data to determine if LHDX.Q's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if LHDX.Q has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LHDX.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.